Iovance Biotherapeutics Inc (NASDAQ: IOVA) stock suffered a major decline of -19.5% on 2/28/25. The shares closed at $4.24. Moreover, trading volume in this decline was exceptionally high at 539% of normal. The stock has declined -24.5% during the last week and has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Iovance Biotherapeutics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Iovance Biotherapeutics has a poor Appreciation Score of 25 and a very low Power Rating of 5, with the Lowest Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment